Therapeutic role of atorvastatin in hypertensive patients with carotid atherosclerosis
Zhang An-xing
Abstract
Zhang An-xing
Abstract
Objective:To investigating the therapeutic role of atorvastatin in hypertensive patients with carotid atherosclerosis. Methods:A total of 182 patients with hypertension of stage 2 and carotid atherosclerosis were average randomly divided into two groups: atorvastatin group (n=91) and routine therapy control group (control group,n=91) and were all given standard treatment of hypertension, but atorvastatin group was given atorvastatin tablets also. The incidence of brain infarction during different period of treatment was observed. Results: Incidence of brain infarction in 3 months of atorvastatin treatment group showed no significant difference with that of control group(1.1% vs. 2.2%, P0.05), but the incidence in two years was significantly lower than that of control group (2.2% vs. 9.9%, P0.05). Conclusion: Atorvastatin can improve the stabilization of atherosclerotic plaque and endothelial function. So it plays an active role in improving the long term prognosis in patients with brain infarction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigating the therapeutic role of atorvastatin in hypertensive patients with carotid atherosclerosis. Methods:A total of 182 patients with hypertension of stage 2 and carotid atherosclerosis were average randomly divided into two groups: atorvastatin group (n=91) and routine therapy control group (control group,n=91) and were all given standard treatment of hypertension, but atorvastatin group was given atorvastatin tablets also. The incidence of brain infarction during different period of treatment was observed. Results: Incidence of brain infarction in 3 months of atorvastatin treatment group showed no significant difference with that of control group(1.1% vs. 2.2%, P0.05), but the incidence in two years was significantly lower than that of control group (2.2% vs. 9.9%, P0.05). Conclusion: Atorvastatin can improve the stabilization of atherosclerotic plaque and endothelial function. So it plays an active role in improving the long term prognosis in patients with brain infarction.
Key concepts: Atorvastatin, Medicine, Incidence (geometry), Internal medicine, Cardiology, Therapeutic effect, Brain infarction, Cerebral infarction